Usnoflast

N/A

Report date: 2025/02/07 10:23:35
NME

Base Information

Drug NameUsnoflast
Drug Alias NameZYIL-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInflammasomes inhibitorsNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsInflammasomesNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsCryopyrin-Associated Periodic SyndromesAmyotrophic Lateral SclerosisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences LtdZydus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCryopyrin-Associated Periodic SyndromesAmyotrophic Lateral SclerosisColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A